Prospective Evaluation of Fetuses With Autoimmune-Associated Congenital Heart Block Followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study
- 15 April 2009
- journal article
- clinical trial
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 103 (8), 1102-1106
- https://doi.org/10.1016/j.amjcard.2008.12.027
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Treatment of fetal heart block with maternal steroid therapy: case report and review of the literatureUltrasound in Obstetrics & Gynecology, 2004
- Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart blockArthritis & Rheumatism, 2004
- The Fetal Doppler Mechanical PR Interval: A Validation StudyFetal Diagnosis and Therapy, 2003
- Repeated courses of antenatal corticosteroids: Is it justified?Acta Obstetricia et Gynecologica Scandinavica, 2003
- Validation of the Doppler PR interval in the fetusJournal of the American Society of Echocardiography, 2002
- Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus GroupAnnals Of The Rheumatic Diseases, 2002
- Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodiesLupus, 2002
- Anti-SSA/Ro and Anti-SSB/La Autoantibodies Bind the Surface of Apoptotic Fetal Cardiocytes and Promote Secretion of TNF-α by MacrophagesThe Journal of Immunology, 2000
- Pulsed Doppler echocardiographic assessment of the fetal PR intervalThe American Journal of Cardiology, 2000
- Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: Retrospective review of the research registry for neonatal lupusArthritis & Rheumatism, 1999